Skip to main content
. 2016 Nov-Dec;5(6):373–376. doi: 10.4103/2303-9027.195870

Figure 3.

Figure 3

G2 malignant neuroendocrine tumor with heterogeneous enhancement. (a) Image immediately after injection. (b) Image 20 s after injection